GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HeXun Biosciences Co Ltd (ROCO:6986) » Definitions » Total Receivables

HeXun Biosciences Co (ROCO:6986) Total Receivables : NT$84.7 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is HeXun Biosciences Co Total Receivables?

HeXun Biosciences Co's Total Receivables for the quarter that ended in Dec. 2024 was NT$84.7 Mil.


HeXun Biosciences Co Total Receivables Historical Data

The historical data trend for HeXun Biosciences Co's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeXun Biosciences Co Total Receivables Chart

HeXun Biosciences Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Total Receivables
- - 4.98 22.28 84.68

HeXun Biosciences Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Receivables Get a 7-Day Free Trial 4.98 12.87 22.28 95.68 84.68

HeXun Biosciences Co Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


HeXun Biosciences Co Total Receivables Related Terms

Thank you for viewing the detailed overview of HeXun Biosciences Co's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


HeXun Biosciences Co Business Description

Traded in Other Exchanges
N/A
Address
Chunri Road, 6 F., No. 1490, Taoyuan District, Taoyuan, TWN
HeXun Biosciences Co Ltd is engaged in the research and development of cell drugs and cell derivatives. It conducts research and development jointly with medical research institutions to use stem cells to treat cardiovascular, immune-inflammatory, and neurodegenerative diseases to develop innovative cell drugs and treatment methods. The company's main business items are new drug research and development, biotechnology services, and research and development services, such as: commissioned research and development and production services for cell medicine, agency testing and development services, and biomedical consulting services, etc.

HeXun Biosciences Co Headlines

No Headlines